封面
市場調查報告書
商品編碼
1602836

抗菌成分市場:按類型、最終用戶分類 - 2025-2030 年全球預測

Antimicrobial Ingredients Market by Type (Inorganic, Organic), End-User (Automotive & Transportation, Building & Construction, Food & Beverage) - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年抗菌成分市值為44.2億美元,預計2024年將達47億美元,複合年成長率為6.79%,預計2030年將達70億美元。

抗菌成分的範圍和定義包括抑制細菌、病毒和真菌等微生物生長的化合物。這些成分對於維持製藥、食品和飲料、個人護理和醫療領域產品的安全性和有效性至關重要。由於衛生和安全意識的提高、感染疾病的爆發以及產品配方的嚴格監管標準,這項需求更加突出。這些成分的應用非常廣泛,包括醫院、食品加工設備和消費品製造等各種最終用途行業中的消毒劑、防腐劑和治療劑。根據市場洞察,關鍵的成長要素包括對天然和永續抗菌解決方案的需求激增、成分合成的技術進步以及強勁的研發活動。由於衛生措施的加強和消費者健康意識的提高,COVID-19 大流行也增加了市場需求,為市場參與企業和現有企業創新和擴大產品系列創造了重要機會。然而,挑戰包括監管障礙、微生物對傳統抗生素具有抗藥性的新興國家的開拓中市場,以及基於化學的選擇可能產生的副作用和毒性。特別是在法律規範嚴格的地區,這可能會阻礙我們產品的核准和商業化。為了利用成長機會,公司需要專注於天然抗菌劑的創新應用,投資於永續且毒性較小的替代品的研究,並建立戰略夥伴關係以在全球範圍內企業發展。此外,我們可以透過加強技術力來提高功效和開發多功能抗菌劑來增強我們的競爭力。該市場的特點是轉向環保和消費者安全的產品,生物分解性和植物來源抗菌藥物的創新和研究被證明是一個利潤豐厚的領域。

主要市場統計
基準年[2023] 44.2億美元
預測年份 [2024] 47億美元
預測年份 [2030] 70億美元
複合年成長率(%) 6.79%

市場動態:揭示快速發展的抗菌成分市場的關鍵市場洞察

供需的動態交互作用正在改變抗菌成分市場。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 提高對健康和衛生問題的認知
    • 對消毒劑和表面消毒劑的需求不斷成長
    • 可支配所得增加,抗菌化妝品採用率上升
  • 市場限制因素
    • 與抗菌成分原料和配方相關的成本上升
  • 市場機會
    • 轉向植物來源抗菌產品
    • 推出新開發的抗菌成分
  • 市場問題
    • 抗菌成分嚴格核准流程

波特五力:引領抗菌成分市場的策略工具

波特的五力框架是了解抗菌成分市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點,避免潛在的挑戰,確保更強大的市場地位。

PESTLE分析:了解抗菌成分市場的外部影響

外部宏觀環境因素對抗菌成分市場的表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並幫助他們做出積極主動的決策。

市場佔有率分析:了解抗菌成分市場競爭狀況

抗菌成分市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣:抗菌成分市場供應商績效評估

FPNV定位矩陣是評估抗菌成分市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商,從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議:繪製抗菌成分市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,抗菌成分市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率:詳細檢視當前市場環境,主要企業的廣泛資料,評估其在市場中的影響力和整體影響力。

2. 市場開拓:辨識新興市場的成長機會,評估現有細分市場的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品和地區提供最佳投資機會?

3.塑造市場的關鍵技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高對健康和衛生問題的認知
      • 消毒劑和表面消毒劑的需求增加
      • 可支配收入的增加和抗菌化妝品的使用增加
    • 抑制因素
      • 與原料和抗菌配方相關的成本增加
    • 機會
      • 植物來源抗菌產品的趨勢
      • 推出新開發的抗菌成分
    • 任務
      • 抗菌成分嚴格的核准流程
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章抗菌成分市場:依類型

  • 介紹
  • 無機的
  • 有機的

第7章抗菌成分市場:依最終用戶分類

  • 介紹
  • 汽車/交通
  • 建築/施工
  • 飲食
  • 醫療保健
  • 纖維

第8章 南北美洲抗菌成分市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太抗菌成分市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東及非洲抗菌成分市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Ashland Global Holdings Inc
  • Avient Corporation
  • BASF SE
  • BioCote Limited
  • Clariant AG
  • Croda International PLC
  • Destiny Pharma PLC
  • DuPont de Nemours, Inc.
  • HeiQ PLC
  • Kemin Industries, Inc.
  • Lonza Group AG
  • LyondellBasell Industries Holdings BV
  • Merck KGaA
  • Microban International, Ltd.
  • Milliken & Company
  • Momentive Performance Materials Inc
  • NATUREX SA
  • Nouryon Chemicals Holding BV
  • Pfizer Inc.
  • RTP Company
  • Sanitized AG
  • Solvay SA
  • Stepan Company
  • Symrise AG
  • Wacker Chemie AG
Product Code: MRR-69324464D0CE

The Antimicrobial Ingredients Market was valued at USD 4.42 billion in 2023, expected to reach USD 4.70 billion in 2024, and is projected to grow at a CAGR of 6.79%, to USD 7.00 billion by 2030.

The scope and definition of antimicrobial ingredients encompass compounds that inhibit the growth of microorganisms such as bacteria, viruses, and fungi. These ingredients are crucial in preserving the safety and efficacy of products in pharmaceuticals, food and beverages, personal care, and healthcare sectors. Their necessity is underscored by rising awareness of hygiene and safety, the increasing prevalence of infectious diseases, and stringent regulatory standards governing product formulations. Applications of these ingredients are broad, spanning disinfectants, preservatives, and therapeutic agents in diverse end-use industries like hospitals, food processing units, and consumer goods manufacturing. Market insights reveal that key growth influencers include the surging demand for natural and sustainable antimicrobial solutions, technological advancements in ingredient synthesis, and robust research and development activities. The COVID-19 pandemic has also augmented market demand due to heightened sanitation measures and a rise in consumer health consciousness, presenting significant opportunities for market entrants and established players to innovate and expand their product portfolios. However, the market is challenged by factors such as regulatory hurdles, the development of resistance by microorganisms against conventional antimicrobials, and the potential side effects or toxicity of some chemical-based options. Limitations are particularly pertinent in regions with stringent regulatory frameworks, which can impede product approvals and commercialization. To capitalize on growth opportunities, businesses should focus on innovative applications of natural antimicrobials, invest in research for sustainable and less toxic alternatives, and engage in strategic partnerships to expand their global reach. Furthermore, enhancing technological capabilities for improved efficacy and developing multi-functional antimicrobials can provide a competitive edge. The market is characterized by a shift towards environmentally friendly and consumer-safe products, indicating a lucrative frontier for innovation and research in biodegradable and plant-based antimicrobials.

KEY MARKET STATISTICS
Base Year [2023] USD 4.42 billion
Estimated Year [2024] USD 4.70 billion
Forecast Year [2030] USD 7.00 billion
CAGR (%) 6.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antimicrobial Ingredients Market

The Antimicrobial Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness regarding health and hygiene issues
    • Growing demand for sanitizers and surface disinfectants
    • Rise in disposable income and higher adoption of antimicrobial cosmetic products
  • Market Restraints
    • Rising costs associated with raw materials and formulation of antimicrobial ingredients
  • Market Opportunities
    • Inclination toward plant-based antimicrobial products
    • Launch of newly developed antimicrobial ingredients
  • Market Challenges
    • Stringent approval processes of antimicrobial ingredients

Porter's Five Forces: A Strategic Tool for Navigating the Antimicrobial Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antimicrobial Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antimicrobial Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antimicrobial Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antimicrobial Ingredients Market

A detailed market share analysis in the Antimicrobial Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antimicrobial Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antimicrobial Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antimicrobial Ingredients Market

A strategic analysis of the Antimicrobial Ingredients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Ingredients Market, highlighting leading vendors and their innovative profiles. These include Ashland Global Holdings Inc, Avient Corporation, BASF SE, BioCote Limited, Clariant AG, Croda International PLC, Destiny Pharma PLC, DuPont de Nemours, Inc., HeiQ PLC, Kemin Industries, Inc., Lonza Group AG, LyondellBasell Industries Holdings B.V., Merck KGaA, Microban International, Ltd., Milliken & Company, Momentive Performance Materials Inc, NATUREX SA, Nouryon Chemicals Holding B.V., Pfizer Inc., RTP Company, Sanitized AG, Solvay SA, Stepan Company, Symrise AG, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inorganic and Organic.
  • Based on End-User, market is studied across Automotive & Transportation, Building & Construction, Food & Beverage, Healthcare, and Textile.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness regarding health and hygiene issues
      • 5.1.1.2. Growing demand for sanitizers and surface disinfectants
      • 5.1.1.3. Rise in disposable income and higher adoption of antimicrobial cosmetic products
    • 5.1.2. Restraints
      • 5.1.2.1. Rising costs associated with raw materials and formulation of antimicrobial ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclination toward plant-based antimicrobial products
      • 5.1.3.2. Launch of newly developed antimicrobial ingredients
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval processes of antimicrobial ingredients
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antimicrobial Ingredients Market, by Type

  • 6.1. Introduction
  • 6.2. Inorganic
  • 6.3. Organic

7. Antimicrobial Ingredients Market, by End-User

  • 7.1. Introduction
  • 7.2. Automotive & Transportation
  • 7.3. Building & Construction
  • 7.4. Food & Beverage
  • 7.5. Healthcare
  • 7.6. Textile

8. Americas Antimicrobial Ingredients Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antimicrobial Ingredients Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antimicrobial Ingredients Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ashland Global Holdings Inc
  • 2. Avient Corporation
  • 3. BASF SE
  • 4. BioCote Limited
  • 5. Clariant AG
  • 6. Croda International PLC
  • 7. Destiny Pharma PLC
  • 8. DuPont de Nemours, Inc.
  • 9. HeiQ PLC
  • 10. Kemin Industries, Inc.
  • 11. Lonza Group AG
  • 12. LyondellBasell Industries Holdings B.V.
  • 13. Merck KGaA
  • 14. Microban International, Ltd.
  • 15. Milliken & Company
  • 16. Momentive Performance Materials Inc
  • 17. NATUREX SA
  • 18. Nouryon Chemicals Holding B.V.
  • 19. Pfizer Inc.
  • 20. RTP Company
  • 21. Sanitized AG
  • 22. Solvay SA
  • 23. Stepan Company
  • 24. Symrise AG
  • 25. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. ANTIMICROBIAL INGREDIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANTIMICROBIAL INGREDIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANTIMICROBIAL INGREDIENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY INORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY ORGANIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY AUTOMOTIVE & TRANSPORTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY BUILDING & CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TEXTILE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ANTIMICROBIAL INGREDIENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ANTIMICROBIAL INGREDIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. ANTIMICROBIAL INGREDIENTS MARKET, FPNV POSITIONING MATRIX, 2023